Found 5 hits for monomerid = 287015 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kcal/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Fibroblast growth factor receptor 1
(Homo sapiens (Human)) | BDBM287015
((R)-8-(3-(4-acryloylpiperazin-1-yl)propyl)-6-(2,6-...)Show SMILES COc1cc(OC)c(Cl)c(c1Cl)-c1cc2cnc(N[C@@H]3CCOC3)nc2n(CCCN2CCN(CC2)C(=O)C=C)c1=O |r,wD:19.19,(1.96,8.47,;3.29,7.7,;3.29,6.16,;4.62,5.39,;4.62,3.85,;5.96,3.08,;7.29,3.85,;3.29,3.08,;3.29,1.54,;1.96,3.85,;1.96,5.39,;.62,6.16,;.62,3.08,;-.71,3.85,;-2.04,3.08,;-3.38,3.85,;-4.71,3.08,;-4.71,1.54,;-6.05,.77,;-6.05,-.77,;-4.8,-1.68,;-5.28,-3.14,;-6.82,-3.14,;-7.29,-1.68,;-3.38,.77,;-2.04,1.54,;-.71,.77,;-.71,-.77,;.62,-1.54,;.62,-3.08,;1.96,-3.85,;1.96,-5.39,;3.29,-6.16,;4.62,-5.39,;4.62,-3.85,;3.29,-3.08,;5.96,-6.16,;7.29,-5.39,;5.96,-7.7,;7.29,-8.47,;.62,1.54,;1.96,.77,)| Show InChI InChI=1S/C29H34Cl2N6O5/c1-4-23(38)36-11-9-35(10-12-36)7-5-8-37-27-18(16-32-29(34-27)33-19-6-13-42-17-19)14-20(28(37)39)24-25(30)21(40-2)15-22(41-3)26(24)31/h4,14-16,19H,1,5-13,17H2,2-3H3,(H,32,33,34)/t19-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 0.700 | n/a | n/a | n/a | n/a | n/a | 25 |
Principia Biopharma, Inc.
US Patent
| Assay Description
A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of FGFR family (FGFR1, FGFR2, FGFR3, FGFR4) kin... |
US Patent US9567334 (2017)
BindingDB Entry DOI: 10.7270/Q2XK8HKQ |
More data for this
Ligand-Target Pair | |
Fibroblast growth factor receptor 1
(Homo sapiens (Human)) | BDBM287015
((R)-8-(3-(4-acryloylpiperazin-1-yl)propyl)-6-(2,6-...)Show SMILES COc1cc(OC)c(Cl)c(c1Cl)-c1cc2cnc(N[C@@H]3CCOC3)nc2n(CCCN2CCN(CC2)C(=O)C=C)c1=O |r,wD:19.19,(1.96,8.47,;3.29,7.7,;3.29,6.16,;4.62,5.39,;4.62,3.85,;5.96,3.08,;7.29,3.85,;3.29,3.08,;3.29,1.54,;1.96,3.85,;1.96,5.39,;.62,6.16,;.62,3.08,;-.71,3.85,;-2.04,3.08,;-3.38,3.85,;-4.71,3.08,;-4.71,1.54,;-6.05,.77,;-6.05,-.77,;-4.8,-1.68,;-5.28,-3.14,;-6.82,-3.14,;-7.29,-1.68,;-3.38,.77,;-2.04,1.54,;-.71,.77,;-.71,-.77,;.62,-1.54,;.62,-3.08,;1.96,-3.85,;1.96,-5.39,;3.29,-6.16,;4.62,-5.39,;4.62,-3.85,;3.29,-3.08,;5.96,-6.16,;7.29,-5.39,;5.96,-7.7,;7.29,-8.47,;.62,1.54,;1.96,.77,)| Show InChI InChI=1S/C29H34Cl2N6O5/c1-4-23(38)36-11-9-35(10-12-36)7-5-8-37-27-18(16-32-29(34-27)33-19-6-13-42-17-19)14-20(28(37)39)24-25(30)21(40-2)15-22(41-3)26(24)31/h4,14-16,19H,1,5-13,17H2,2-3H3,(H,32,33,34)/t19-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 0.700 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharmaceuticals Inc.
| Assay Description
A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of FGFR family (FGFR1, FGFR2, FGFR3, FGFR4) kin... |
Bioorg Med Chem Lett 19: 773-7 (2009)
BindingDB Entry DOI: 10.7270/Q2GX4DVZ |
More data for this
Ligand-Target Pair | |
Fibroblast growth factor receptor 1
(Homo sapiens (Human)) | BDBM287015
((R)-8-(3-(4-acryloylpiperazin-1-yl)propyl)-6-(2,6-...)Show SMILES COc1cc(OC)c(Cl)c(c1Cl)-c1cc2cnc(N[C@@H]3CCOC3)nc2n(CCCN2CCN(CC2)C(=O)C=C)c1=O |r,wD:19.19,(1.96,8.47,;3.29,7.7,;3.29,6.16,;4.62,5.39,;4.62,3.85,;5.96,3.08,;7.29,3.85,;3.29,3.08,;3.29,1.54,;1.96,3.85,;1.96,5.39,;.62,6.16,;.62,3.08,;-.71,3.85,;-2.04,3.08,;-3.38,3.85,;-4.71,3.08,;-4.71,1.54,;-6.05,.77,;-6.05,-.77,;-4.8,-1.68,;-5.28,-3.14,;-6.82,-3.14,;-7.29,-1.68,;-3.38,.77,;-2.04,1.54,;-.71,.77,;-.71,-.77,;.62,-1.54,;.62,-3.08,;1.96,-3.85,;1.96,-5.39,;3.29,-6.16,;4.62,-5.39,;4.62,-3.85,;3.29,-3.08,;5.96,-6.16,;7.29,-5.39,;5.96,-7.7,;7.29,-8.47,;.62,1.54,;1.96,.77,)| Show InChI InChI=1S/C29H34Cl2N6O5/c1-4-23(38)36-11-9-35(10-12-36)7-5-8-37-27-18(16-32-29(34-27)33-19-6-13-42-17-19)14-20(28(37)39)24-25(30)21(40-2)15-22(41-3)26(24)31/h4,14-16,19H,1,5-13,17H2,2-3H3,(H,32,33,34)/t19-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| | n/a | n/a | 0.700 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Fibroblast growth factor receptor 1
(Homo sapiens (Human)) | BDBM287015
((R)-8-(3-(4-acryloylpiperazin-1-yl)propyl)-6-(2,6-...)Show SMILES COc1cc(OC)c(Cl)c(c1Cl)-c1cc2cnc(N[C@@H]3CCOC3)nc2n(CCCN2CCN(CC2)C(=O)C=C)c1=O |r,wD:19.19,(1.96,8.47,;3.29,7.7,;3.29,6.16,;4.62,5.39,;4.62,3.85,;5.96,3.08,;7.29,3.85,;3.29,3.08,;3.29,1.54,;1.96,3.85,;1.96,5.39,;.62,6.16,;.62,3.08,;-.71,3.85,;-2.04,3.08,;-3.38,3.85,;-4.71,3.08,;-4.71,1.54,;-6.05,.77,;-6.05,-.77,;-4.8,-1.68,;-5.28,-3.14,;-6.82,-3.14,;-7.29,-1.68,;-3.38,.77,;-2.04,1.54,;-.71,.77,;-.71,-.77,;.62,-1.54,;.62,-3.08,;1.96,-3.85,;1.96,-5.39,;3.29,-6.16,;4.62,-5.39,;4.62,-3.85,;3.29,-3.08,;5.96,-6.16,;7.29,-5.39,;5.96,-7.7,;7.29,-8.47,;.62,1.54,;1.96,.77,)| Show InChI InChI=1S/C29H34Cl2N6O5/c1-4-23(38)36-11-9-35(10-12-36)7-5-8-37-27-18(16-32-29(34-27)33-19-6-13-42-17-19)14-20(28(37)39)24-25(30)21(40-2)15-22(41-3)26(24)31/h4,14-16,19H,1,5-13,17H2,2-3H3,(H,32,33,34)/t19-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 6.40 | n/a | n/a | n/a | n/a | n/a | n/a |
PRINCIPIA BIOPHARMA, INC.
US Patent
| Assay Description
A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of FGFR family (FGFR1, FGFR2, FGFR3, FGFR4) kin... |
US Patent US9815834 (2017)
BindingDB Entry DOI: 10.7270/Q2B85B83 |
More data for this
Ligand-Target Pair | |
Fibroblast growth factor receptor 2
(Homo sapiens (Human)) | BDBM287015
((R)-8-(3-(4-acryloylpiperazin-1-yl)propyl)-6-(2,6-...)Show SMILES COc1cc(OC)c(Cl)c(c1Cl)-c1cc2cnc(N[C@@H]3CCOC3)nc2n(CCCN2CCN(CC2)C(=O)C=C)c1=O |r,wD:19.19,(1.96,8.47,;3.29,7.7,;3.29,6.16,;4.62,5.39,;4.62,3.85,;5.96,3.08,;7.29,3.85,;3.29,3.08,;3.29,1.54,;1.96,3.85,;1.96,5.39,;.62,6.16,;.62,3.08,;-.71,3.85,;-2.04,3.08,;-3.38,3.85,;-4.71,3.08,;-4.71,1.54,;-6.05,.77,;-6.05,-.77,;-4.8,-1.68,;-5.28,-3.14,;-6.82,-3.14,;-7.29,-1.68,;-3.38,.77,;-2.04,1.54,;-.71,.77,;-.71,-.77,;.62,-1.54,;.62,-3.08,;1.96,-3.85,;1.96,-5.39,;3.29,-6.16,;4.62,-5.39,;4.62,-3.85,;3.29,-3.08,;5.96,-6.16,;7.29,-5.39,;5.96,-7.7,;7.29,-8.47,;.62,1.54,;1.96,.77,)| Show InChI InChI=1S/C29H34Cl2N6O5/c1-4-23(38)36-11-9-35(10-12-36)7-5-8-37-27-18(16-32-29(34-27)33-19-6-13-42-17-19)14-20(28(37)39)24-25(30)21(40-2)15-22(41-3)26(24)31/h4,14-16,19H,1,5-13,17H2,2-3H3,(H,32,33,34)/t19-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 6.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharmaceuticals Inc.
| Assay Description
The cell-based effects of FGFR inhibitors were determined by measuring inhibition of FGFR-dependent cell line growth. The cell lines SNU-16 was used ... |
Bioorg Med Chem Lett 19: 773-7 (2009)
BindingDB Entry DOI: 10.7270/Q2GX4DVZ |
More data for this
Ligand-Target Pair | |
Search and Browse
